Loading…
Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children
Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching,...
Saved in:
Published in: | Pediatrics (Evanston) 2019-07, Vol.144 (1), p.1 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273 |
---|---|
cites | cdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273 |
container_end_page | |
container_issue | 1 |
container_start_page | 1 |
container_title | Pediatrics (Evanston) |
container_volume | 144 |
creator | Boruta, Mary Boruta, Richard Li, Jennifer |
description | Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals |
doi_str_mv | 10.1542/peds.2019-0909 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2251105609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2258735659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</originalsourceid><addsrcrecordid>eNpdkD1PwzAURS0EoqWwMqJILGVIeXbiOB6rio9KFQyUOXLsFzUliYPdIPXfk9DCwPSkp3Ovrg4h1xRmlMfsvkXjZwyoDEGCPCFjCjINYyb4KRkDRDSMAfiIXHi_BYCYC3ZORhGlgtNYjMnLXJcmeOva1qH3pW2C9QadaveBavr_vm53tg6WdevsF9bY7IKpdcFK6Y8fEG1xF5RNsNiUlXHYXJKzQlUer453Qt4fH9aL53D1-rRczFehjpJoF7JYy5gVIi0o50aqHJTUXGmaiARzCRoRhATFchC5Tk1qDEZGp5AKmQAT0YRMD739rs8O_S6rS6-xqlSDtvMZY5xS4AnIHr39h25t55p-3UClIuIJH6jZgdLOeu-wyFpX1srtMwrZYDobTGeD6Www3QdujrVdXqP5w3_VRt91fnhq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258735659</pqid></control><display><type>article</type><title>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Boruta, Mary ; Boruta, Richard ; Li, Jennifer</creator><creatorcontrib>Boruta, Mary ; Boruta, Richard ; Li, Jennifer</creatorcontrib><description>Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals <2 years old.1 At 4 months of age, 67% of children have daily regurgitation. Parents report a perceived problem with GER in 23% of 6-month-old infants.2 This high rate of concern results in GER being a common complaint in outpatient and inpatient settings. Combined with the ready availability of acid suppression therapy, this has led to increased prescribing of both H2RAs and PPIs in both infants and older children.3,4 Acid suppression therapy has been previously viewed as benign; however, recent research has revealed that these medications may carry risk.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.2019-0909</identifier><identifier>PMID: 31175147</identifier><language>eng</language><publisher>United States: American Academy of Pediatrics</publisher><subject>Acids ; Antacids ; Child ; Child, Preschool ; Children ; Gastroesophageal Reflux ; Histamine ; Humans ; Infants ; Proton pump inhibitors ; Regurgitation ; Secondary Prevention ; Treatment Outcome ; Vomiting</subject><ispartof>Pediatrics (Evanston), 2019-07, Vol.144 (1), p.1</ispartof><rights>Copyright American Academy of Pediatrics Jul 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</citedby><cites>FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31175147$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boruta, Mary</creatorcontrib><creatorcontrib>Boruta, Richard</creatorcontrib><creatorcontrib>Li, Jennifer</creatorcontrib><title>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals <2 years old.1 At 4 months of age, 67% of children have daily regurgitation. Parents report a perceived problem with GER in 23% of 6-month-old infants.2 This high rate of concern results in GER being a common complaint in outpatient and inpatient settings. Combined with the ready availability of acid suppression therapy, this has led to increased prescribing of both H2RAs and PPIs in both infants and older children.3,4 Acid suppression therapy has been previously viewed as benign; however, recent research has revealed that these medications may carry risk.</description><subject>Acids</subject><subject>Antacids</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Gastroesophageal Reflux</subject><subject>Histamine</subject><subject>Humans</subject><subject>Infants</subject><subject>Proton pump inhibitors</subject><subject>Regurgitation</subject><subject>Secondary Prevention</subject><subject>Treatment Outcome</subject><subject>Vomiting</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpdkD1PwzAURS0EoqWwMqJILGVIeXbiOB6rio9KFQyUOXLsFzUliYPdIPXfk9DCwPSkp3Ovrg4h1xRmlMfsvkXjZwyoDEGCPCFjCjINYyb4KRkDRDSMAfiIXHi_BYCYC3ZORhGlgtNYjMnLXJcmeOva1qH3pW2C9QadaveBavr_vm53tg6WdevsF9bY7IKpdcFK6Y8fEG1xF5RNsNiUlXHYXJKzQlUer453Qt4fH9aL53D1-rRczFehjpJoF7JYy5gVIi0o50aqHJTUXGmaiARzCRoRhATFchC5Tk1qDEZGp5AKmQAT0YRMD739rs8O_S6rS6-xqlSDtvMZY5xS4AnIHr39h25t55p-3UClIuIJH6jZgdLOeu-wyFpX1srtMwrZYDobTGeD6Www3QdujrVdXqP5w3_VRt91fnhq</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Boruta, Mary</creator><creator>Boruta, Richard</creator><creator>Li, Jennifer</creator><general>American Academy of Pediatrics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20190701</creationdate><title>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</title><author>Boruta, Mary ; Boruta, Richard ; Li, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acids</topic><topic>Antacids</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Gastroesophageal Reflux</topic><topic>Histamine</topic><topic>Humans</topic><topic>Infants</topic><topic>Proton pump inhibitors</topic><topic>Regurgitation</topic><topic>Secondary Prevention</topic><topic>Treatment Outcome</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boruta, Mary</creatorcontrib><creatorcontrib>Boruta, Richard</creatorcontrib><creatorcontrib>Li, Jennifer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boruta, Mary</au><au>Boruta, Richard</au><au>Li, Jennifer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>144</volume><issue>1</issue><spage>1</spage><pages>1-</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><abstract>Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals <2 years old.1 At 4 months of age, 67% of children have daily regurgitation. Parents report a perceived problem with GER in 23% of 6-month-old infants.2 This high rate of concern results in GER being a common complaint in outpatient and inpatient settings. Combined with the ready availability of acid suppression therapy, this has led to increased prescribing of both H2RAs and PPIs in both infants and older children.3,4 Acid suppression therapy has been previously viewed as benign; however, recent research has revealed that these medications may carry risk.</abstract><cop>United States</cop><pub>American Academy of Pediatrics</pub><pmid>31175147</pmid><doi>10.1542/peds.2019-0909</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0031-4005 |
ispartof | Pediatrics (Evanston), 2019-07, Vol.144 (1), p.1 |
issn | 0031-4005 1098-4275 |
language | eng |
recordid | cdi_proquest_miscellaneous_2251105609 |
source | EZB-FREE-00999 freely available EZB journals |
subjects | Acids Antacids Child Child, Preschool Children Gastroesophageal Reflux Histamine Humans Infants Proton pump inhibitors Regurgitation Secondary Prevention Treatment Outcome Vomiting |
title | Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acid%20Suppression%20Therapy%20and%20Symptom%20Improvement%20(or%20Lack%20Thereof)%20in%20Children&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Boruta,%20Mary&rft.date=2019-07-01&rft.volume=144&rft.issue=1&rft.spage=1&rft.pages=1-&rft.issn=0031-4005&rft.eissn=1098-4275&rft_id=info:doi/10.1542/peds.2019-0909&rft_dat=%3Cproquest_cross%3E2258735659%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2258735659&rft_id=info:pmid/31175147&rfr_iscdi=true |